Ministerio de Industria, Turismo y Comercio LogoMinisterior
 

Alerta

Resultados 58 results.
LastUpdate Updated on 29/08/2025 [07:31:00]
pdfxls
Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days
previousPage Results 50 to 58 of 58  

AGENTS, USES AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHY

Publication No.:  EP4582144A2 09/07/2025
Applicant: 
H LUNDBECK AS [DK]
H. Lundbeck A/S
EP_4582144_A2

Absstract of: EP4582144A2

The invention relates to novel monoclonal anti-alpha-synuclein antibodies. The antibodies can be used for treating a synucleinopathy such as Parkinson's disease (including idiopathic and inherited forms of Parkinson's disease), Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheimer's disease (LBV), Combined Alzheimer's and Parkinson disease, pure autonomic failure and multiple system atrophy.

COMPOSITIONS AND METHODS OF USING HisGTG TRANSFER RNAS (tRNAs)

Publication No.:  US2025215504A1 03/07/2025
Applicant: 
THOMAS JEFFERSON UNIV [US]
Thomas Jefferson University
US_2025215504_A1

Absstract of: US2025215504A1

The present invention includes a method for analyzing tRNAHisGTG fragments. In one aspect, the present invention includes a method of identifying a subject in need of therapeutic intervention to treat and/or prevent a disease or condition, disease recurrence, or disease progression comprises characterizing the identity of tRNAHisGTG fragments. The invention further includes diagnosing, identifying or monitoring a disease or condition, a panel of engineered oligonucleotides, a kit for a high-throughput assay, and a method and system for identifying tRNAHisGTG fragments.

APOLIPOPROTEIN E DETECTION REAGENT AND USE THEREOF

Publication No.:  WO2025138512A1 03/07/2025
Applicant: 
SHANGHAI LIONRUN BIOMEDICINE TECH CO LTD [CN]
\u4E0A\u6D77\u826F\u6DA6\u751F\u7269\u533B\u836F\u79D1\u6280\u6709\u9650\u516C\u53F8
CN_117886933_PA

Absstract of: WO2025138512A1

Provided are an apolipoprotein E detection reagent and the use thereof. The reagent comprises at least one of an ApoE2 protein detection reagent, an ApoE3 protein detection reagent and an ApoE4 protein detection reagent. One of a capture antibody and a detection antibody used for detecting ApoE2 protein or ApoE4 protein is a specific monoclonal antibody, and the capture antibody and the detection antibody used for detecting ApoE3 are both specific monoclonal antibodies. Genotyping of ApoE and quantitative detection of different genotypes of proteins are performed on the basis of an immunological detection method. The detection method has the advantages of being simple, easy to operate, short in time and cheap. A genotype detection result is highly consistent with a fluorescence PCR result. Genotyping of ApoE (6 types) can be performed, which is used to replace the nucleic acid detection and guide medication, and clarify the correlation of the ApoE4 genotype homozygosity/heterozygosity and the protein concentration of ApoE4 with AD.

ANTI-TREM2 SINGLE-DOMAIN ANTIBODY AND USE THEREOF

Publication No.:  EP4578872A1 02/07/2025
Applicant: 
REGENECORE BIOTECH CO LTD [CN]
Regenecore Biotech Co., Ltd
EP_4578872_PA

Absstract of: EP4578872A1

Provided is an anti-TREM2 single-domain antibody, consisting of heavy chains comprising CDR1 represented by any one of SEQ ID NOs: 34-40, CDR2 represented by any one of SEQ ID NOs: 41-45, and CDR3 represented by any one of SEQ ID NOs: 46-50. The single-domain antibody has good affinity with TREM2.

ANTI-TAU MTBR ANTIBODIES AND METHODS TO DETECT CLEAVED FRAGMENTS OF TAU AND USES THEREOF

Publication No.:  EP4577567A2 02/07/2025
Applicant: 
WASHINGTON UNIVERSITY ST LOUIS [US]
Washington University
KR_20250075748_PA

Absstract of: CN119744269A

Provided herein are antibodies or fragments thereof that specifically bind to the microtubule binding region (MTBR) of tau, and uses thereof. Further provided are methods of detecting MTBR species in blood or cerebrospinal fluid, as well as the use of such detection for diagnosing, prognosing or staging pathological characteristics and/or clinical symptoms of tauopathy, and selecting a treatment suitable for a given disease stage.

DNA DNA APTAMERS SPECIFICALLY BINDING TO TRANSTHYRETIN PROTEIN AND USE THEREOF

Publication No.:  KR20250099577A 02/07/2025
Applicant: 
NAT UNIV CHUNGBUK IND ACAD COOP FOUND [KR]
\uCDA9\uBD81\uB300\uD559\uAD50 \uC0B0\uD559\uD611\uB825\uB2E8
KR_20250099577_PA

Absstract of: KR20250099577A

본 발명은 트랜스타이레틴(transthyretin, TTR) 단백질에 특이적으로 결합하고 특정 폴리뉴클레오티드 서열로 구성되는 DNA 앱타머 및 상기 DNA 앱타머의 용도에 관한 것이다. 구체적으로, 본 발명에 따른 DNA 앱타머는 트랜스타이레틴 단백질에 특이적으로 강하게 결합함으로써, 상기 DNA 앱타머는 트렌스타이레틴 단백질의 검출이나, 트랜스타이레틴 단백질의 발현 수준이 유의적으로 높아진 것으로 알려진 퇴행성뇌질환의 진단에 유용하게 사용될 수 있다.

METHOD FOR MEASURING CELL FREE CHROMATIN

Publication No.:  EP4577833A1 02/07/2025
Applicant: 
BELGIAN VOLITION SRL [BE]
Belgian Volition SRL
WO_2024042210_PA

Absstract of: WO2024042210A1

The invention relates to methods and uses of cell free histone H3 isoforms H3.1, H3.2, H3t and/or H3.3 (or cell free nucleosomes containing said isoforms) of determining the origin of a cell free histone or cell free nucleosome in a body fluid sample as originating from a dividing or non-dividing cell.

METHOD FOR THE DETECTION OF DEMENTIA

Nº publicación: EP4577835A1 02/07/2025

Applicant:

BELGIAN VOLITION SRL [BE]
Belgian Volition SRL

AU_2023329158_PA

Absstract of: AU2023329158A1

The invention relates to methods of detecting, diagnosing or monitoring an inflammatory condition of the central nervous system, in particular by detecting or measuring neutrophil extracellular traps, extracellular traps and/or cell free nucleosomes.

traducir